News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
142,109 Results
Type
Article (11151)
Company Profile (54)
Press Release (130904)
Multimedia
Podcasts (3)
Webinars (3)
Section
Business (40965)
Career Advice (113)
Deals (7229)
Drug Delivery (9)
Drug Development (19376)
Employer Resources (14)
FDA (3359)
Job Trends (2815)
News (71012)
Policy (6419)
Tag
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2026 Genetown Elite (1)
Academia (716)
Accelerated approval (1)
Adcomms (5)
Allergies (8)
Alliances (14182)
ALS (26)
Alzheimer's disease (367)
Antibody-drug conjugate (ADC) (18)
Approvals (3393)
Artificial intelligence (53)
Autoimmune disease (2)
Automation (3)
Bankruptcy (22)
Best Places to Work (2503)
BIOSECURE Act (3)
Biosimilars (26)
Biotechnology (52)
Bladder cancer (16)
Brain cancer (9)
Breast cancer (55)
Cancer (499)
Cardiovascular disease (36)
Career advice (100)
Career pathing (1)
CAR-T (35)
Cell therapy (122)
Clinical research (15507)
Collaboration (258)
Compensation (80)
Complete response letters (6)
COVID-19 (533)
CRISPR (25)
C-suite (46)
Cystic fibrosis (62)
Data (589)
Depression (4)
Diabetes (39)
Diagnostics (1986)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (39)
Drug pricing (4)
Duchenne muscular dystrophy (52)
Earnings (13616)
Editorial (6)
Employer branding (3)
Employer resources (13)
Events (18088)
Executive appointments (129)
FDA (3682)
Featured Employer (13)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (162)
Gene editing (68)
Generative AI (2)
Gene therapy (172)
GLP-1 (108)
Government (676)
Grass and pollen (1)
Guidances (10)
Healthcare (3213)
Huntington's disease (7)
IgA nephropathy (7)
Immunology and inflammation (10)
Indications (9)
Infectious disease (559)
Inflammatory bowel disease (38)
Inflation Reduction Act (1)
Influenza (10)
Intellectual property (25)
Interviews (14)
IPO (3016)
IRA (1)
Job creations (490)
Job search strategy (97)
Kidney cancer (1)
Labor market (2)
Layoffs (59)
Legal (1303)
Liver cancer (22)
Lung cancer (63)
Lymphoma (41)
Management (1)
Manufacturing (64)
MASH (9)
Medical device (1383)
Medtech (1384)
Mergers & acquisitions (4374)
Metabolic disorders (114)
Multiple sclerosis (17)
NASH (2)
Neurodegenerative disease (28)
Neuropsychiatric disorders (2)
Neuroscience (516)
NextGen: Class of 2025 (919)
Non-profit (711)
Northern California (563)
Now hiring (4)
Obesity (62)
Opinion (37)
Ovarian cancer (11)
Pain (12)
Pancreatic cancer (19)
Parkinson's disease (48)
Partnered (4)
Patents (40)
Patient recruitment (18)
People (11435)
Pharmaceutical (6)
Phase I (5190)
Phase II (6882)
Phase III (5343)
Pipeline (290)
Policy (9)
Postmarket research (438)
Preclinical (2155)
Press Release (20)
Prostate cancer (14)
Psychedelics (3)
Radiopharmaceuticals (36)
Rare diseases (201)
Real estate (1036)
Recruiting (3)
Regulatory (4968)
Reports (11)
Research institute (845)
Resumes & cover letters (11)
Rett syndrome (4)
RNA editing (4)
RSV (1)
Schizophrenia (11)
Series A (36)
Series B (18)
Service/supplier (2)
Sickle cell disease (20)
Southern California (431)
Special edition (2)
Spinal muscular atrophy (133)
Sponsored (6)
Startups (966)
Stomach cancer (1)
Supply chain (12)
Tariffs (1)
The Weekly (3)
United States (4590)
Vaccines (91)
Venture capitalists (5)
Weight loss (12)
Women's health (3)
Date
Today (47)
Last 7 days (197)
Last 30 days (579)
Last 365 days (7665)
2025 (2326)
2024 (8278)
2023 (9196)
2022 (13869)
2021 (13765)
2020 (11951)
2019 (8845)
2018 (6729)
2017 (7373)
2016 (6641)
2015 (8023)
2014 (5865)
2013 (4846)
2012 (4799)
2011 (4901)
2010 (4437)
Location
Africa (164)
Alabama (4)
Alaska (2)
Arizona (22)
Arkansas (1)
Asia (23896)
Australia (3006)
California (1221)
Canada (396)
China (195)
Colorado (37)
Connecticut (53)
Delaware (12)
Europe (21584)
Florida (116)
Georgia (14)
Idaho (4)
Illinois (42)
India (12)
Indiana (82)
Iowa (1)
Japan (101)
Kansas (10)
Kentucky (4)
Louisiana (3)
Maine (6)
Maryland (178)
Massachusetts (1153)
Michigan (49)
Minnesota (33)
Missouri (6)
Montana (2)
Nebraska (5)
Nevada (9)
New Hampshire (3)
New Jersey (356)
New Mexico (3)
New York (382)
North Carolina (205)
North Dakota (4)
Northern California (563)
Ohio (34)
Oklahoma (1)
Oregon (5)
Pennsylvania (261)
Rhode Island (5)
South America (214)
South Carolina (1)
Southern California (431)
Tennessee (2)
Texas (144)
Utah (80)
Virginia (45)
Washington D.C. (9)
Washington State (112)
Wisconsin (13)
142,109 Results for "touchlight genetics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Curia expands biologics capabilities with access to Touchlight’s doggybone DNACuria collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™)
Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia and its clients a streamlined means of access to Touchlight’s doggybone DNA (dbDNA).
July 24, 2023
·
2 min read
Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study
Touchlight announced that the Company has used its proprietary dbDNA as a critical starting material for manufacturing of VMB-100, a potency enhanced messenger ribonucleic acid encoding human insulin-like growth factor-1 to support Versameb’s first-in-human clinical study to treat chronic stress urinary incontinence.
November 21, 2023
·
4 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
FDA Accepts Drug Master File, Signifying a New Milestone for Touchlight’s Enzymatic doggybone DNA Technology
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, today announced a ground-breaking new milestone for its enzymatic doggybone DNA (dbDNA™), following the FDA acceptance of the Drug Master File (DMF) for GMP grade dbDNA.
January 24, 2023
·
3 min read
FDA
Touchlight Announces First FDA Clearance of an IND Utilising Doggybone DNA
Touchlight, a CDMO pioneering enzymatic DNA production to enable genetic medicines, today announced the first FDA clearance of an Investigational New Drug (IND) application in the US utilising doggybone DNA (dbDNA™).
February 28, 2023
·
2 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
Polyrizon Ltd. Announces $17.0 Million Private Placement
April 1, 2025
·
5 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
1 of 14,211
Next
